Trillium Therapeutics (acquired 2013) Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.85M
Trillium Therapeutics (acquired 2013) General Information
Description
Developer of protein therapeutics. The company focuses on immune regulation and cytoprotection.
Contact Information
Corporate Office
- 96 Skyway Avenue
- Toronto, Ontario M9W 4Y9
- Canada
Corporate Office
- 96 Skyway Avenue
- Toronto, Ontario M9W 4Y9
- Canada
Trillium Therapeutics (acquired 2013) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 09-Apr-2013 | $2.85M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 12-May-2011 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 22-May-2009 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 18-Sep-2008 | $12M | $25.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 05-Feb-2004 | $13.5M | $13.5M | Completed | Product Development |
Trillium Therapeutics (acquired 2013) Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BDC Capital | Growth/Expansion | Minority | ||
| GrowthWorks | Venture Capital | Minority | ||
| MaRS Investment Accelerator Fund | Venture Capital | Minority | ||
| VenGrowth Asset Management | Venture Capital | Minority |
Trillium Therapeutics (acquired 2013) FAQs
-
When was Trillium Therapeutics (acquired 2013) founded?
Trillium Therapeutics (acquired 2013) was founded in 1996.
-
Where is Trillium Therapeutics (acquired 2013) headquartered?
Trillium Therapeutics (acquired 2013) is headquartered in Toronto, Canada.
-
What industry is Trillium Therapeutics (acquired 2013) in?
Trillium Therapeutics (acquired 2013)’s primary industry is Biotechnology.
-
Is Trillium Therapeutics (acquired 2013) a private or public company?
Trillium Therapeutics (acquired 2013) is a Private company.
-
What is the current valuation of Trillium Therapeutics (acquired 2013)?
The current valuation of Trillium Therapeutics (acquired 2013) is .
-
What is Trillium Therapeutics (acquired 2013)’s current revenue?
The current revenue for Trillium Therapeutics (acquired 2013) is .
-
How much funding has Trillium Therapeutics (acquired 2013) raised over time?
Trillium Therapeutics (acquired 2013) has raised $32.9M.
-
Who are Trillium Therapeutics (acquired 2013)’s investors?
BDC Capital, GrowthWorks, MaRS Investment Accelerator Fund, and VenGrowth Asset Management have invested in Trillium Therapeutics (acquired 2013).
-
When was Trillium Therapeutics (acquired 2013) acquired?
Trillium Therapeutics (acquired 2013) was acquired on 09-Apr-2013.
-
Who acquired Trillium Therapeutics (acquired 2013)?
Trillium Therapeutics (acquired 2013) was acquired by Trillium Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process